title: Extensive and severe CNS demyelination associated with golimumab therapy.
authors.affiliation: Neurology Department, Pitié-Salpêtrière Hospital, APHP, 47-83 Boulevard de l'hôpital, 75013, Paris, France. elisabeth.maillart@aphp.fr.
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Maillart
authors.affiliation: Neurology Department, Pitié-Salpêtrière Hospital, APHP, 47-83 Boulevard de l'hôpital, 75013, Paris, France.
authors.forename: Caroline
authors.initials: C
authors.lastname: Papeix
authors.affiliation: Neuroradiology Department, Sainte-Anne Hospital, Centre de Psychiatrie et Neurosciences, INSERM U894, Paris, France.|Neuroradiology Department, XV-XX Hospital, Paris, France.
authors.forename: Charles
authors.initials: C
authors.lastname: Mellerio
authors.affiliation: Diagnostic and Functional Neuroradiology Department, Pitié-Salpêtrière Hospital, APHP, Paris, France.
authors.forename: Anne
authors.initials: A
authors.lastname: Bertrand
authors.affiliation: Neurology Department, Pitié-Salpêtrière Hospital, APHP, 47-83 Boulevard de l'hôpital, 75013, Paris, France.
authors.forename: Catherine
authors.initials: C
authors.lastname: Lubetzki
authors.affiliation: Neurology Department, Pitié-Salpêtrière Hospital, APHP, 47-83 Boulevard de l'hôpital, 75013, Paris, France.
authors.forename: Céline
authors.initials: C
authors.lastname: Louapre
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000000981:diagnostic imaging / Q000188:drug therapy; D001921:Brain / Q000000981:diagnostic imaging / Q000187:drug effects; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007155:Immunologic Factors; C529000:golimumab